Caricamento...
Effects of octreotide on hepatic glycogenesis in rats with high fat diet-induced obesity
Reduced hepatic glycogenesis is one of the most important causes of metabolic abnormalities in non-alcoholic fatty liver disease. Octreotide, a somatostatin analogue, has been demonstrated to promote weight loss and improve metabolic disorders in mice with high fat diet (HFD)-induced obesity. Howeve...
Salvato in:
| Pubblicato in: | Mol Med Rep |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5482138/ https://ncbi.nlm.nih.gov/pubmed/28534956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2017.6586 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|